TWD 151.0
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.45 Billion TWD | -33.04% |
2022 | 2.16 Billion TWD | 11.38% |
2021 | 1.94 Billion TWD | 2.79% |
2020 | 1.89 Billion TWD | -2.24% |
2019 | 1.93 Billion TWD | 49.65% |
2018 | 1.29 Billion TWD | -4.18% |
2017 | 1.35 Billion TWD | 4.25% |
2016 | 1.29 Billion TWD | 23.31% |
2015 | 1.05 Billion TWD | 11.58% |
2014 | 942.48 Million TWD | 12.77% |
2013 | 835.76 Million TWD | 35.04% |
2012 | 618.9 Million TWD | 30.83% |
2011 | 473.06 Million TWD | 10.61% |
2010 | 427.7 Million TWD | 12.75% |
2009 | 379.34 Million TWD | 130.57% |
2008 | 164.52 Million TWD | -9.04% |
2007 | 180.87 Million TWD | 20.24% |
2006 | 150.42 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 327.75 Million TWD | 27.1% |
2024 Q1 | 257.88 Million TWD | -44.94% |
2023 Q2 | 337.87 Million TWD | -17.74% |
2023 Q1 | 410.75 Million TWD | -40.99% |
2023 Q4 | 468.32 Million TWD | 27.7% |
2023 Q3 | 366.74 Million TWD | 8.54% |
2023 FY | 1.45 Billion TWD | -33.04% |
2022 Q3 | 542.8 Million TWD | -4.65% |
2022 FY | 2.16 Billion TWD | 11.38% |
2022 Q2 | 569.27 Million TWD | 57.46% |
2022 Q1 | 361.53 Million TWD | -17.84% |
2022 Q4 | 696.07 Million TWD | 28.24% |
2021 Q3 | 302.03 Million TWD | -7.3% |
2021 FY | 1.94 Billion TWD | 2.79% |
2021 Q1 | 232.53 Million TWD | -44.75% |
2021 Q2 | 325.82 Million TWD | 40.12% |
2021 Q4 | 440.03 Million TWD | 45.69% |
2020 Q1 | 262.69 Million TWD | -38.64% |
2020 Q3 | 303.6 Million TWD | 6.6% |
2020 Q4 | 420.91 Million TWD | 38.64% |
2020 Q2 | 284.8 Million TWD | 8.42% |
2020 FY | 1.89 Billion TWD | -2.24% |
2019 FY | 1.93 Billion TWD | 49.65% |
2019 Q3 | 304 Million TWD | -3.24% |
2019 Q2 | 314.18 Million TWD | 19.6% |
2019 Q1 | 262.69 Million TWD | -35.45% |
2019 Q4 | 428.14 Million TWD | 40.84% |
2018 Q1 | 260.31 Million TWD | -41.16% |
2018 Q4 | 406.92 Million TWD | 20.13% |
2018 Q3 | 338.74 Million TWD | 17.05% |
2018 FY | 1.29 Billion TWD | -4.18% |
2018 Q2 | 289.4 Million TWD | 11.18% |
2017 Q3 | 329.66 Million TWD | 2.68% |
2017 Q1 | 258.82 Million TWD | -32.86% |
2017 Q2 | 321.05 Million TWD | 24.04% |
2017 Q4 | 442.39 Million TWD | 34.2% |
2017 FY | 1.35 Billion TWD | 4.25% |
2016 Q1 | 283.16 Million TWD | -8.03% |
2016 FY | 1.29 Billion TWD | 23.31% |
2016 Q4 | 385.52 Million TWD | 15.9% |
2016 Q3 | 332.64 Million TWD | 12.59% |
2016 Q2 | 295.43 Million TWD | 4.33% |
2015 Q2 | 244.32 Million TWD | 2.75% |
2015 Q1 | 237.79 Million TWD | -18.39% |
2015 FY | 1.05 Billion TWD | 11.58% |
2015 Q4 | 307.9 Million TWD | 17.69% |
2015 Q3 | 261.63 Million TWD | 7.08% |
2014 Q3 | 245.83 Million TWD | 16.7% |
2014 Q2 | 210.64 Million TWD | 8.24% |
2014 Q1 | 194.61 Million TWD | -23.9% |
2014 FY | 942.48 Million TWD | 12.77% |
2014 Q4 | 291.39 Million TWD | 18.53% |
2013 Q4 | 255.73 Million TWD | 24.2% |
2013 Q2 | 200.95 Million TWD | 16.04% |
2013 FY | 835.76 Million TWD | 35.04% |
2013 Q1 | 173.17 Million TWD | 2.19% |
2013 Q3 | 205.91 Million TWD | 2.47% |
2012 Q3 | 155.09 Million TWD | 11.77% |
2012 Q2 | 138.76 Million TWD | -8.56% |
2012 Q1 | 151.75 Million TWD | 11.29% |
2012 FY | 618.9 Million TWD | 30.83% |
2012 Q4 | 169.46 Million TWD | 9.27% |
2011 Q2 | 135.37 Million TWD | 0.78% |
2011 Q1 | 134.33 Million TWD | -11.87% |
2011 Q4 | 136.36 Million TWD | 103.55% |
2011 FY | 473.06 Million TWD | 10.61% |
2011 Q3 | 66.99 Million TWD | -50.51% |
2010 Q4 | 152.42 Million TWD | 47.81% |
2010 FY | 427.7 Million TWD | 12.75% |
2010 Q3 | 103.12 Million TWD | -3.59% |
2010 Q2 | 106.96 Million TWD | 64.09% |
2010 Q1 | 65.18 Million TWD | 0.0% |
2009 FY | 379.34 Million TWD | 130.57% |
2008 FY | 164.52 Million TWD | -9.04% |
2007 FY | 180.87 Million TWD | 20.24% |
2006 FY | 150.42 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Standard Chem & Pharm CO., LTD. | 834.88 Million TWD | -74.003% |
Maywufa Company Ltd. | 169.09 Million TWD | -759.104% |
ScinoPharm Taiwan, Ltd. | 287.05 Million TWD | -406.078% |
Lotus Pharmaceutical Co., Ltd. | 4.1 Billion TWD | 64.616% |
LIWANLI Innovation Co., Ltd. | 5.1 Million TWD | -28368.117% |
YungShin Global Holding Corporation | 827.3 Million TWD | -75.598% |
PhytoHealth Corporation | -47.11 Million TWD | 3183.235% |
SCI Pharmtech, Inc. | 294.72 Million TWD | -392.916% |
Formosa Laboratories, Inc. | 126.24 Million TWD | -1050.739% |
PharmaEssentia Corporation | -623.83 Million TWD | 332.871% |
Bora Pharmaceuticals Co., LTD. | 3.03 Billion TWD | 52.057% |